Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12035-021-02383-0 http://scihub22266oqcxt.onion/10.1007/s12035-021-02383-0 33829393!8026389!33829393     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33829393&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mol+Neurobiol 2021 ; 58 (8): 3787-3791 Nephropedia Template TP {{tp|p=33829393|t=2021. Clinical and Pathophysiologic Spectrum of Neuro-COVID |pdf=|usr=}}{{33829393}} gab.com Text Clinical and Pathophysiologic Spectrum of Neuro-COVID JO: Mol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=33829393 #FOAvip Though the lungs are predominantly affected in SARS-CoV-2-infected patients, extra-pulmonary manifestations can occur. Extra-pulmonary manifestations of the central and peripheral nervous system need to be recognised as they can strongly determine the outcome. This mini-review summarises and discusses previous and recent findings about neuro-COVID. The spectrum of central nervous system disease in COVID-19 patients is much broader than so far anticipated. Peripheral nerves and the skeletal muscle are less predominantly affected. In the vast majority of the cases, there is no direct attack of the virus towards vulnerable structures, which explains why various manifestations of the nervous system manifest favourably to immune suppression or immune modulation. Overall, the pathophysiology and clinical presentation of CNS/PNS involvement in COVID-19 is wider than believed. All patients with COVID-19 should be investigated by the neurologist for primary or secondary involvement of the CNS/PNS in the infection. neuro-COVID responds favourably to immune suppressants or immune modulation. Twit Text FOAVip Clinical and Pathophysiologic Spectrum of Neuro-COVID ????Mol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=33829393 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33829393 #FOAvip English Wikipedia <ref>{{Cite pmid|33829393}}</ref> Clinical and Pathophysiologic Spectrum of Neuro-COVID #MMPMID33829393 Finsterer J; Scorza FA Mol Neurobiol 2021[Aug]; 58 (8): 3787-3791 PMID33829393show ga Though the lungs are predominantly affected in SARS-CoV-2-infected patients, extra-pulmonary manifestations can occur. Extra-pulmonary manifestations of the central and peripheral nervous system need to be recognised as they can strongly determine the outcome. This mini-review summarises and discusses previous and recent findings about neuro-COVID. The spectrum of central nervous system disease in COVID-19 patients is much broader than so far anticipated. Peripheral nerves and the skeletal muscle are less predominantly affected. In the vast majority of the cases, there is no direct attack of the virus towards vulnerable structures, which explains why various manifestations of the nervous system manifest favourably to immune suppression or immune modulation. Overall, the pathophysiology and clinical presentation of CNS/PNS involvement in COVID-19 is wider than believed. All patients with COVID-19 should be investigated by the neurologist for primary or secondary involvement of the CNS/PNS in the infection. neuro-COVID responds favourably to immune suppressants or immune modulation. |Antiviral Agents/adverse effects/pharmacology/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*physiopathology[MESH] |Epitopes/immunology[MESH] |Humans[MESH] |Nervous System Diseases/*physiopathology[MESH]Clinical and Pathophysiologic Spectrum of Neuro-COVID (epmc).pdf DeepDyve Pubget Overpricing